PUBLISHER: The Business Research Company | PRODUCT CODE: 1948649
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948649
A wearable infusion pump is a portable medical device designed to deliver controlled doses of medication or fluids over extended periods while being worn on the body, allowing continuous or scheduled infusion with greater convenience for patients.
The main types of wearable infusion pumps include electronic ambulatory infusion pumps, patient-controlled analgesia (PCA) pumps, large-volume pumps, syringe pumps, and others. Electronic ambulatory infusion pumps are portable devices that use electronic control systems to deliver accurate and continuous medication doses over a set period. These pumps are available in disposable and reusable formats and are used in applications such as diabetes management, antibiotic delivery, chemotherapy, pain management, Parkinson's disease treatment, and others.
Tariffs have increased the cost of imported electronic components, sensors, batteries, and precision plastics used in wearable infusion pumps, raising overall manufacturing and device prices. These impacts are most significant in electronic ambulatory pumps and insulin pump segments, particularly in Asia-Pacific and Europe where component sourcing is highly globalized. Higher prices have affected affordability for hospitals and home care users, potentially slowing device upgrades. However, tariffs have also encouraged local assembly and component sourcing, strengthening regional manufacturing bases and improving long term supply chain resilience.
The wearable infusion pumps market research report is one of a series of new reports from The Business Research Company that provides wearable infusion pumps market statistics, including wearable infusion pumps industry global market size, regional shares, competitors with a wearable infusion pumps market share, detailed wearable infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the wearable infusion pumps industry. This wearable infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The wearable infusion pumps market size has grown strongly in recent years. It will grow from $1.51 billion in 2025 to $1.65 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to rising prevalence of diabetes and chronic diseases, advancement in insulin delivery technology, demand for patient-centric care, expansion of home healthcare, growing awareness of wearable infusion systems.
The wearable infusion pumps market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to adoption of AI-based dose optimization, integration with smartphone and cloud platforms, growth in multi-drug delivery applications, demand for compact and portable wearable pumps, increasing telehealth services for chronic care management. Major trends in the forecast period include smart wearable insulin pumps, remote monitoring and telehealth integration, ai-driven dose optimization, multi-drug infusion systems, compact and portable device designs.
The increasing prevalence of chronic diseases is increasingly supporting the expansion of the wearable infusion pump market going forward. Chronic diseases are long-term health conditions that progress slowly and persist for extended periods, often requiring continuous medical care. Major chronic diseases include cancer, heart disease, diabetes, and arthritis. The prevalence of chronic diseases continues to rise due to genetic, environmental, and lifestyle-related factors, including poor diet, physical inactivity, and exposure to harmful substances. Wearable infusion pumps assist chronic disease patients by enabling continuous and precise medication delivery, improving adherence, and optimizing treatment outcomes. For example, in June 2024, according to the National Health Service, a UK-based publicly funded healthcare system, 3,615,330 individuals in England were registered with a GP for non-diabetic hyperglycemia in 2023, reflecting an 18% year-on-year increase. As a result, the growing prevalence of chronic diseases is reinforcing demand for wearable infusion pumps.
Leading companies operating in the wearable infusion pump market are developing advanced products such as tubeless, wearable, and disposable insulin pumps to improve user convenience, treatment adherence, and discreet insulin delivery. Tubeless wearable insulin pumps are small, skin-adhered devices that deliver continuous insulin without external tubing and are replaced after a defined period. For example, in February 2023, GulfDrug LLC, a UAE-based healthcare company, launched EOPatch, a tubeless, wearable, and disposable insulin pump controlled via Android and iOS smartphones using the Narsha app. The device offers up to 84 hours of continuous insulin delivery and integrates diabetes data management into a single smartphone platform.
In June 2023, Lohmann Therapie-Systeme AG (LTS), a Germany-based drug delivery systems company, acquired Sorrel from Eitan Medical for $100 million. Through this acquisition, LTS aims to broaden its drug delivery systems portfolio by integrating Sorrel, a wearable drug delivery platform developed by Eitan Medical. Eitan Medical is an Israel-based company specializing in advanced infusion and drug delivery solutions, including wearable infusion pumps such as patient-controlled epidural analgesia systems, designed to enhance patient care through innovative technology.
Major companies operating in the wearable infusion pumps market are Fresenius SE & Co. KGaA, Medtronic Plc, Medline Industries Inc., Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, ICU Medical Inc., Insulet Corporation, Sorenson Medical, Avanos Medical Inc., Vygon SA, pfm medical GmbH, Eitan Medical, Micrel Medical Devices SA, Zyno Medical LLC, Q-Core Medical Ltd., Epic Medical Solutions, MOOG Inc., Smiths Medical International Ltd
North America was the largest region in the wearable infusion pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the wearable infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the wearable infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The wearable infusion pump market consists of sales of infusion sets, reservoirs, and adhesive patches. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Wearable Infusion Pumps Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses wearable infusion pumps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for wearable infusion pumps ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The wearable infusion pumps market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.